XLV

Equity ETF Channel

17 Highly Targeted Sector ETFs for Late Business Cycle

By Max ChenMay 1, 2019

Webcasts

How Sectors Can Help with a Changing Market

By Max ChenApril 30, 2019

Relative Value Channel

12 Biggest Healthcare ETFs Ready for Sector Rebound

By Tom LydonApril 24, 2019

Core ETF Channel

After a Rough Week, Healthcare ETFs Could Bounce Back

By Todd ShriberApril 24, 2019

Equity ETF Channel

Why Biggest Healthcare ETF ‘XLV’ Has Been Sick

By Tom LydonApril 19, 2019

Innovative ETFs Channel

Healthcare, Biotech ETFs Plunge on Mounting Political Pressures

By Max ChenApril 18, 2019

Innovative ETFs Channel

Healthcare ETFs Lag the Broader Market Amidst Regulation Scare

By Max ChenApril 15, 2019

Equity ETF Channel

Tom Lydon on CNBC: Can Health Care Cure Itself?

By Ben HernandezApril 15, 2019

Relative Value Channel

Will Tighter Government Regulation Test Health Care ETFs?

By Ben HernandezApril 15, 2019

Innovative ETFs Channel

Healthcare ETFs Deteriorate on Congress’ Threats to Drug Prices

By Max ChenApril 12, 2019

Equity ETF Channel

Getting Selective With Healthcare Stocks

By Brenton GarenApril 9, 2019

Leveraged & Inverse Channel

Health Care ETFs Get a Boost From Latest Jobs Report

By Ben HernandezApril 6, 2019

Innovative ETFs Channel

Bullish on CVS? Look to Hot Healthcare ETFs

By Max ChenMarch 13, 2019

Innovative ETFs Channel

Healthcare, Biotech ETFs XLV and XBI Slide on FDA’s Uncertain Outlook

By Max ChenMarch 6, 2019

Core ETF Channel

It’s Time to Prescribe Healthcare ETFs

By Tom LydonJanuary 23, 2019

Core ETF Channel

Healthcare ETFs Slip After Abbot Lab’s Revenue Miss, Weak Outlook

By Max ChenJanuary 23, 2019

Equity ETFs

Some Value Remains With HealthCare ETFs

By Brenton GarenJanuary 5, 2019

Equity ETFs

Healthcare ETFs Could Lead Again in 2019

By Tom LydonJanuary 4, 2019